112 related articles for article (PubMed ID: 26225690)
1. Clinical Characteristics Associated with Long-term Survival in Metastatic Gastric Cancer after Systemic Chemotherapy.
Kadowaki S; Komori A; Takahari D; Ura T; Ito S; Tajika M; Niwa Y; Oze I; Muro K
Asian Pac J Cancer Prev; 2015; 16(13):5433-8. PubMed ID: 26225690
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2.
Turkeli M; Aldemir MN; Cayir K; Simsek M; Bilici M; Tekin SB; Yildirim N; Bilen N; Makas I
Asian Pac J Cancer Prev; 2015; 16(3):985-9. PubMed ID: 25735393
[TBL] [Abstract][Full Text] [Related]
3. Improving trends in survival of patients who receive chemotherapy for metastatic or recurrent gastric cancer: 12 years of experience at a single institution.
Koo DH; Ryu MH; Ryoo BY; Seo J; Lee MY; Chang HM; Lee JL; Lee SS; Kim TW; Kang YK
Gastric Cancer; 2015 Apr; 18(2):346-53. PubMed ID: 24832201
[TBL] [Abstract][Full Text] [Related]
4. Baseline Sarcopenia and Skeletal Muscle Loss During Chemotherapy Affect Survival Outcomes in Metastatic Gastric Cancer.
Sugiyama K; Narita Y; Mitani S; Honda K; Masuishi T; Taniguchi H; Kadowaki S; Ura T; Ando M; Tajika M; Muro K
Anticancer Res; 2018 Oct; 38(10):5859-5866. PubMed ID: 30275211
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in first-line chemotherapy treated metastatic gastric cancer patients: a retrospective study.
Inal A; Kaplan MA; Kuçukoner M; Urakci Z; Guven M; Nas N; Yunce M; Işikdogan A
Asian Pac J Cancer Prev; 2012; 13(8):3869-72. PubMed ID: 23098485
[TBL] [Abstract][Full Text] [Related]
6. Chemoresponse after non-curative gastrectomy for M1 gastric cancer.
Shin HB; Lee SH; Son YG; Ryu SW; Sohn SS
World J Surg Oncol; 2015 Jan; 13():13. PubMed ID: 25634223
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy.
Li QQ; Lu ZH; Yang L; Lu M; Zhang XT; Li J; Zhou J; Wang XC; Gong JF; Gao J; Li J; Li Y; Shen L
Asian Pac J Cancer Prev; 2014; 15(2):945-50. PubMed ID: 24568523
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.
Liu DJ; Fu XL; Liu W; Zheng LY; Zhang JF; Huo YM; Li J; Hua R; Liu Q; Sun YW
World J Gastroenterol; 2017 Jan; 23(3):516-524. PubMed ID: 28210088
[TBL] [Abstract][Full Text] [Related]
9. Palliative distal gastrectomy offers no survival benefit over gastrojejunostomy for gastric cancer with outlet obstruction: retrospective analysis of an 11-year experience.
Okumura Y; Yamashita H; Aikou S; Yagi K; Yamagata Y; Nishida M; Mori K; Nomura S; Kitayama J; Watanabe T; Seto Y
World J Surg Oncol; 2014 Nov; 12():364. PubMed ID: 25432703
[TBL] [Abstract][Full Text] [Related]
10. Survival of gastric cancer with concomitant liver metastases.
Kwok CM; Wu CW; Lo SS; Shen KH; Hsieh MC; Lui WY
Hepatogastroenterology; 2004; 51(59):1527-30. PubMed ID: 15362793
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes and prognostic factors of metastatic gastric carcinoma patients who experience gastrointestinal perforation during palliative chemotherapy.
Kang MH; Kim SN; Kim NK; Park YI; Kim YW; Ryu KW; Lee JH; Lee JS; Park SR
Ann Surg Oncol; 2010 Dec; 17(12):3163-72. PubMed ID: 20585878
[TBL] [Abstract][Full Text] [Related]
12. Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial.
Li J; Qin S; Xu J; Guo W; Xiong J; Bai Y; Sun G; Yang Y; Wang L; Xu N; Cheng Y; Wang Z; Zheng L; Tao M; Zhu X; Ji D; Liu X; Yu H
J Clin Oncol; 2013 Sep; 31(26):3219-25. PubMed ID: 23918952
[TBL] [Abstract][Full Text] [Related]
13. Palliative gastrectomy and chemotherapy for stage IV gastric cancer.
Lin SZ; Tong HF; You T; Yu YJ; Wu WJ; Chen C; Zhang W; Ye B; Li CM; Zhen ZQ; Xu JR; Zhou JL
J Cancer Res Clin Oncol; 2008 Feb; 134(2):187-92. PubMed ID: 17611776
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Okada K; Mori M; Doki Y
Ann Surg Oncol; 2011 Dec; 18(13):3726-31. PubMed ID: 21584835
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study.
Yoshida M; Ohtsu A; Boku N; Miyata Y; Shirao K; Shimada Y; Hyodo I; Koizumi W; Kurihara M; Yoshida S; Yamamoto S
Jpn J Clin Oncol; 2004 Nov; 34(11):654-9. PubMed ID: 15613554
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of gastric cancer patients with bone marrow metastases.
Kim HS; Yi SY; Jun HJ; Lee J; Park JO; Park YS; Jang J; Kim HJ; Ko Y; Lim HY; Kang WK
Oncology; 2007; 73(3-4):192-7. PubMed ID: 18418012
[TBL] [Abstract][Full Text] [Related]
17. The Role of Surgical Resection for Stage IV Gastric Cancer With Synchronous Hepatic Metastasis.
Picado O; Dygert L; Macedo FI; Franceschi D; Sleeman D; Livingstone AS; Merchant N; Yakoub D
J Surg Res; 2018 Dec; 232():422-429. PubMed ID: 30463751
[TBL] [Abstract][Full Text] [Related]
18. Randomized prospective phase II study to compare the combination chemotherapy regimen epirubicin, cisplatin, and 5-fluorouracil with epirubicin, cisplatin, and capecitabine in patients with advanced or metastatic gastric cancer.
Ocvirk J; Reberšek M; Skof E; Hlebanja Z; Boc M
Am J Clin Oncol; 2012 Jun; 35(3):237-41. PubMed ID: 21399488
[TBL] [Abstract][Full Text] [Related]
19. Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study.
Li Z; Fan B; Shan F; Tang L; Bu Z; Wu A; Zhang L; Wu X; Zong X; Li S; Ren H; Ji J
World J Surg Oncol; 2015 Jul; 13():212. PubMed ID: 26126412
[TBL] [Abstract][Full Text] [Related]
20. Glasgow prognostic score is a useful predictive factor of outcome after palliative gastrectomy for stage IV gastric cancer.
Mimatsu K; Oida T; Fukino N; Kano H; Kawasaki A; Kida K; Kuboi Y; Amano S
Anticancer Res; 2014 Jun; 34(6):3131-6. PubMed ID: 24922683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
